Oryzon Genomics S.A. (LON:0RDB)
London
· Delayed Price · Currency is GBP · Price in EUR 2.735
0.00 (0.00%)
At close: Apr 17, 2025
Oryzon Genomics Market Cap
Oryzon Genomics has a market cap or net worth of 173.14 million as of May 2, 2025. Its market cap has increased by 66.45% in one year.
Market Cap
173.14M
Enterprise Value
182.16M
Revenue
6.09M
Ranking
n/a
PE Ratio
n/a
Stock Price
2.74
Market Cap Chart
Since December 14, 2015, Oryzon Genomics's market cap has increased from 88.97M to 173.14M, an increase of 94.60%. That is a compound annual growth rate of 7.35%.
Market Cap History
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AstraZeneca | 164.49B |
| GSK plc | 59.24B |
| Haleon | 35.06B |
| Smith & Nephew | 9.43B |
| ConvaTec Group | 5.35B |
| Hikma Pharmaceuticals | 4.41B |
| HUTCHMED (China) | 1.94B |
| Genus | 1.31B |